Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-16 Sale | 2024-01-18 6:18 pm | AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner | 100,000 | $19.65 | $1,965,000 | 2,373,500 (Indirect Direct) | View |
| 2023-11-14 Sale | 2023-11-16 6:59 pm | AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner | 1,810 | $16.15 | $29,224 | 2,473,500 (Indirect Direct) | View |
| 2023-09-29 Sale | 2023-10-03 7:13 pm | AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner | 104,773 | $16.27 | $1,704,513 | 2,475,310 (Indirect Direct) | View |
| 2023-09-27 Sale | 2023-09-29 5:41 pm | AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner | 9,357 | $16.11 | $150,708 | 2,580,083 (Indirect Direct) | View |
| 2023-09-13 Sale | 2023-09-15 5:17 pm | AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner | 400 | $16 | $6,400 | 2,589,440 (Indirect Direct) | View |
| 2023-09-06 Sale | 2023-09-08 4:59 pm | AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner | 7,140 | $16.03 | $114,484 | 2,589,840 (Indirect Direct) | View |
| 2023-08-23 Sale | 2023-08-25 4:31 pm | AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner | 400 | $16 | $6,400 | 2,596,980 (Indirect Direct) | View |
| 2022-03-29 Purchase(A) | 2022-06-24 4:51 pm | AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner | 166,666 | $15 | $2,499,990 | 2,597,380 (Indirect Direct) | View |
| 2022-03-29 Purchase | 2022-03-31 8:15 pm | AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. 10% Owner | 166,666 | $15 | $2,499,990 | 2,210,735 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-06 Other | 2022-06-24 5:06 pm | N/A N/A | AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner | 26,511 | $15 | 2,650,402 (Direct) | View |
| 2022-03-29 Conversion(A) | 2022-06-24 4:51 pm | N/A N/A | AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner | 2,430,714 | $0 | 2,597,380 (Direct) | View |
Ownership(A) | 2022-06-24 4:48 pm | N/A N/A | AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. Adjuvant Capital GP L.P. Adjuvant Capital Management LLC 10% Owner | 0 | $0 | 2,430,714 (Direct) | View |
| 2022-03-29 Conversion | 2022-03-31 8:15 pm | N/A N/A | AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. 10% Owner | 2,430,714 | $0 | 2,210,735 (Indirect) | View |
Ownership | 2022-03-24 9:16 pm | N/A N/A | AN2 Therapeutics Inc. | ANTX | Adjuvant Global Health Technology Fund L.P. Adjuvant Global Health Technology Fund DE L.P. 10% Owner | 0 | $0 | 2,430,714 (Indirect) | View |